CGAS and neoplasm: Taken together, metallic nanomedicines hold significant promise in enhancing antitumor immune responses, either by directly activating innate immune pathways such as cGAS–STING or by potentiating PTT or RT-induced tumor ablation and subsequent ICD effects.